Neuroprotective effect of vildagliptin against cerebral ischemia in rats

[1]  Dian-xu Yang,et al.  Hydrogen postconditioning promotes survival of rat retinal ganglion cells against ischemia/reperfusion injury through the PI3K/Akt pathway. , 2018, Biochemical and biophysical research communications.

[2]  Dong-Mei Wu,et al.  Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  N. Chattipakorn,et al.  SGLT2‐inhibitor and DPP‐4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD‐induced obese rats , 2017, Toxicology and applied pharmacology.

[4]  R. Abd-Elsalam,et al.  Tiron ameliorates oxidative stress and inflammation in titanium dioxide nanoparticles induced nephrotoxicity of male rats. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Xiufang Li,et al.  Preventive treatment of astaxanthin provides neuroprotection through suppression of reactive oxygen species and activation of antioxidant defense pathway after stroke in rats , 2017, Brain Research Bulletin.

[6]  N. Chattipakorn,et al.  DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats , 2017, Scientific Reports.

[7]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[8]  J. Jaworski,et al.  Molecular neurobiology of mTOR , 2017, Neuroscience.

[9]  Xueqin Ma,et al.  Neuroprotective effect and mechanism of Mu-Xiang-You-Fang on cerebral ischemia-reperfusion injury in rats. , 2016, Journal of ethnopharmacology.

[10]  Xiaofeng Yu,et al.  Neuroprotective effects of Kaempferide-7-O-(4″-O-acetylrhamnosyl)-3-O-rutinoside on cerebral ischemia-reperfusion injury in rats. , 2016, European journal of pharmacology.

[11]  N. Chattipakorn,et al.  Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats. , 2016, The Journal of endocrinology.

[12]  Ke-Li Chen,et al.  Protective effect of n-butyl alcohol extracts from Rhizoma Pinelliae Pedatisectae against cerebral ischemia-reperfusion injury in rats. , 2016, Journal of ethnopharmacology.

[13]  T. Nyström,et al.  Gliptin‐mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon‐like peptide‐1 receptor , 2016, Diabetes, obesity & metabolism.

[14]  Jun Xiang,et al.  PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats. , 2016, Journal of ethnopharmacology.

[15]  C. Molina,et al.  Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care. , 2016, European journal of internal medicine.

[16]  A. Abdel‐Rahman,et al.  Role of adenosine A2A receptor in cerebral ischemia reperfusion injury: Signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1/2) , 2016, Neuroscience.

[17]  S. Yagihashi,et al.  The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes , 2016, Journal of neurochemistry.

[18]  I. Younos,et al.  Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. , 2015, European journal of pharmacology.

[19]  Bhupesh Sharma,et al.  Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia , 2015, Physiology & Behavior.

[20]  R. Abdelsalam,et al.  Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE‐NFκB and Nrf2‐antioxidant signaling pathways , 2015, Journal of neurochemistry.

[21]  M. Fang,et al.  Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation , 2015, Front. Neuroanat..

[22]  Lei Zhang,et al.  Activation of the Nrf2 defense pathway contributes to neuroprotective effects of phloretin on oxidative stress injury after cerebral ischemia/reperfusion in rats , 2015, Journal of the Neurological Sciences.

[23]  H. Hara,et al.  Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling. , 2015, Biochemical and biophysical research communications.

[24]  S. Briyal,et al.  Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia , 2014, Neuroscience.

[25]  Yu Ye,et al.  Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway , 2014, Journal of the Neurological Sciences.

[26]  C. J. Kim,et al.  Inhibitory Effects of Isoquinoline Alkaloid Berberine on Ischemia-Induced Apoptosis via Activation of Phosphoinositide 3-Kinase/Protein Kinase B Signaling Pathway , 2014, International neurourology journal.

[27]  Rongling Zhong,et al.  Neuroprotective Effects of Rhynchophylline Against Ischemic Brain Injury via Regulation of the Akt/mTOR and TLRs Signaling Pathways , 2014, Molecules.

[28]  Wei Wu,et al.  Protective Effect of Glycyrrhizin, a Direct HMGB1 Inhibitor, on Focal Cerebral Ischemia/Reperfusion-Induced Inflammation, Oxidative Stress, and Apoptosis in Rats , 2014, PloS one.

[29]  N. Chattipakorn,et al.  Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart , 2014, Diabetes & vascular disease research.

[30]  Guohong Li,et al.  Role of Inflammation and Its Mediators in Acute Ischemic Stroke , 2013, Journal of Cardiovascular Translational Research.

[31]  R. Holsinger,et al.  Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease , 2013, Neuropharmacology.

[32]  Bassant M M Ibrahim,et al.  Effect of Boswellia serrata on Alzheimer′s disease induced in rats , 2013, Journal of The Arab Society for Medical Research.

[33]  T. Kawaguchi,et al.  Dipeptidyl peptidase-4: a key player in chronic liver disease. , 2013, World journal of gastroenterology.

[34]  N. Chattipakorn,et al.  DPP4‐inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high‐fat diet consumption , 2013, The European journal of neuroscience.

[35]  Young Sup Kim,et al.  Comparison of neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient cerebral ischemic damage. , 2012, Fitoterapia.

[36]  Shaohui Wang,et al.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR. , 2012, Future neurology.

[37]  Huiqing Liu,et al.  Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation , 2012, Brain Research Bulletin.

[38]  T. Xiong,et al.  Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations , 2012, Reviews in the neurosciences.

[39]  F. Striggow,et al.  Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia , 2012, Journal of Neuroinflammation.

[40]  S. Dejager,et al.  Mechanisms of action of the dipeptidyl peptidase‐4 inhibitor vildagliptin in humans , 2011, Diabetes, obesity & metabolism.

[41]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[42]  A. Lochner,et al.  Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats , 2011, Cardiovascular Drugs and Therapy.

[43]  K. Yoo,et al.  Long-term changes in neuronal degeneration and microglial activation in the hippocampal CA1 region after experimental transient cerebral ischemic damage , 2010, Brain Research.

[44]  S. Lakhan,et al.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches , 2009, Journal of Translational Medicine.

[45]  Marc Fisher,et al.  Stroke , 2008, The Lancet.

[46]  K. Maiese,et al.  OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. , 2008, Trends in molecular medicine.

[47]  M. Heffer-Lauc,et al.  Activity cage as a method to analyze functional recovery after sciatic nerve injury in mice , 2007, Somatosensory & motor research.

[48]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[49]  D. Drucker,et al.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes , 2006, The Lancet.

[50]  G. Bing,et al.  Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease , 2006, Journal of Neuroinflammation.

[51]  T. Kortemme,et al.  Ionization-reactivity relationships for cysteine thiols in polypeptides. , 1998, Biochemistry.

[52]  M. Ruiz-Larrea,et al.  Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes , 1994, Steroids.

[53]  Jun Chen,et al.  Human Copper‐Zinc Superoxide Dismutase Transgenic Mice Are Highly Resistant to Reperfusion Injury After Focal Cerebral Ischemia , 1994, Stroke.

[54]  J. Bancroft,et al.  Theory and Practice of Histological Techniques , 1990 .

[55]  A. Álvarez-Buylla,et al.  Cresyl violet: A red fluorescent Nissl stain , 1990, Journal of Neuroscience Methods.

[56]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[57]  O. Paulson.  Cerebral Apoplexy (Stroke): Pathogenesis, Pathophysiology and Therapy as Illustrated by Regional Blood Flow Measurements in the Brain , 1971, Stroke.

[58]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[59]  Shaohui Wang,et al.  mTOR: on target for novel therapeutic strategies in the nervous system. , 2013, Trends in molecular medicine.

[60]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.